The
PDZ domain of SCRIB binds directly to the
human papillomavirus E6 protein. SCRIB is targeted for
ubiquitination by a complex of E6 and
UBE3A and E6 induces degradation of SCRIB. In human cells expressing
oncogenic Ras or Raf, it was found the loss of SCRIB resulted in the invasion of the
extracellular matrix by various cell types. This is believed to be a direct result of regulation of the
MAP Kinase pathway by SCRIB.
Role in epithelial mesenchymal transition (EMT) Due to its role in
cell polarity and
cell motility, SCRIB has also been implicated in
epithelial mesenchymal transition (EMT), which is linked to tumor
metastasis and proliferation in many
cancers. EMT is implicated in cancer progression by allowing static
epithelial cells to become migratory and allowing these cells to adapt to as well as colonize new environments. In cancerous epithelial tissues, SCRIB is found primarily in the cytosol as opposed to its usual location in the membrane, thus further implicating a role in tumor progression and EMT for SCRIB. Knockdown mutants have resulted in the loss of adhesion between Madin-Darby canine kidney epithelial cells. This loss of adhesion was correlated with an acquired
mesenchymal appearance, an increase in motility, and loss of directionality. These effects were a direct result of the interruption of
E-cadherin-mediated cellular adhesion. A decrease in cell migration and an overall decrease in cell motility markers as well as
epithelial mesenchymal transition mediators was also observed in small lung adenocarcinoma cells that were depleted of SCRIB. == References ==